For the first time, the neuroprotective potential of mGlu7R allosteric agonist AMN082 against TBI injury was found in the in vivo model in rats [187]. These findings demonstrated that (ip)administered AMN082 three times, immediately-, 24- and 48 h after TBI diminished TBI-induced cerebral c...